









Markets
/
Stocks
/
nasdaq-life
/

aTyr Pharma Ord Shs

LIFE

10.130USD

+0.030+0.30%

Close 03/27, 16:00（ET）Quotes delayed by 15 min

633.72MMarket Cap

8.91P/E TTM



aTyr Pharma Ord Shs

10.130

+0.030+0.30%

Overview Financials Analysis Company

Overview

Financials

Analysis

Company

Cash Flow Statement

You can access the annual and quarterly cash flow statements of aTyr Pharma Ord Shs to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q4

FY2025Q3

Operating cash flows (indirect method)

Cash flow from continuing operating activities

--4.94M

--7.25M

Net income from continuing operations

--24.56M

--15.87M

Operating gains losses

--1.28M

--1.33M

Deferred tax

--1.14M

--1.87M

Other non-cash items

---8.00K

---242.00K

Change in working capital

---22.83M

---12.64M

-Change in receivables

---23.87M

---12.86M

-Change in prepaid expenses

---5.49M

---5.14M

-Change in payables and accrued expense

----

--18.00K

-Change in other current assets

--26.00K

--113.00K

-Change in other current liabilities

--2.73M

---11.84M

Cash from non-recurring investing activities

Cash from operating activities

--4.94M

--7.25M

Investing cash flow

Net cash from continuing investing activities

--2.03M

--1.87M

Capital expenditures

--2.03M

--1.87M

Net cash flow from disposal of fixed assets

--390.00K

--523.00K

Net cash flow from intangible asset transactions

--1.64M

--1.35M

Net cash flow from investment products

--10.78M

--3.77M

Net cash flow from other investing activities

--0.00

----

Cash from non-current investing activities

Net cash flow from investing activities

--8.75M

--1.90M

Financing cash flow

Cash flow from continuous financing activities

---6.87M

---5.14M

Net cash flow from debt Issuance/repayment

---4.15M

---3.09M

Net cash flow from common stock issuance/repurchase

----

--29.75M

Proceeds from stock option exercised by employees

--264.00K

--4.00K

Net cash flow from other financing activities

---2.98M

---2.06M

Net cash from non-recurrent financing activities

Net cash from financing activities

---6.87M

---5.14M

Net cash flow

Beginning cash balance

--84.27M

--80.28M

Current period cash flow changes

--6.82M

--3.98M

Effect of exchange rate changes

---8.00K

---18.00K

Ending cash balance

--91.09M

--84.27M

Free cash flow

--2.91M

--5.38M

Currency unit

USD

Audit opinions

FAQs

What is the cash flow statement?



This report tracks the movement of cash into and out of the business, covering operating, investing, and financing activities. It highlights how well the company manages cash to support growth and meet its obligations.

KeyAI

